Quick Answer
InspireMD, Inc. reported Research And Development Expense of $15.00 million for the year ending 2025.
- InspireMD, Inc. showed an increase of +10.0% in Research And Development Expense from 2024 to 2025.
- This data is from InspireMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), InspireMD, Inc.'s Research And Development Expense has grown by 1,028.0%.
- Historical annual values: Fiscal year 2025: $15.00 million | Fiscal year 2024: $13.63 million | Fiscal year 2023: $7.98 million | Fiscal year 2022: $7.81 million | Fiscal year 2021: $5.16 million | Fiscal year 2020: $2.23 million | Fiscal year 2019: $2.95 million | Fiscal year 2018: $1.54 million | Fiscal year 2017: $1.28 million | Fiscal year 2016: $1.29 million | Fiscal year 2015: $3.64 million | Fiscal year 2014: $8.74 million | Fiscal year 2013: $4.16 million | Fiscal year 2012: $3.99 million | Fiscal year 2011: $2.47 million | Fiscal year 2010: $1.34 million | Fiscal year 2009: $1.33 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: